Egelund EF - Search Results

1

Integrase Inhibitors: After 10 Years of Experience, Is the Best Yet to Come?

Brooks KM, Sherman EM, Egelund EF, Brotherton A, Durham S, Badowski ME, Cluck DB. Brooks KM, et al. Among authors: egelund ef. Pharmacotherapy. 2019 May;39(5):576-598. doi: 10.1002/phar.2246. Epub 2019 Apr 1. Pharmacotherapy. 2019. PMID: 30860610 Review.

2

A HAART-Breaking Review of Alternative Antiretroviral Administration: Practical Considerations with Crushing and Enteral Tube Scenarios.

Huesgen E, DeSear KE, Egelund EF, Smith R, Max B, Janelle J. Huesgen E, et al. Among authors: egelund ef. Pharmacotherapy. 2016 Nov;36(11):1145-1165. doi: 10.1002/phar.1835. Epub 2016 Oct 20. Pharmacotherapy. 2016. PMID: 27636237 Review.

3

Tenofovir Alafenamide for the Treatment of Chronic Hepatitis B Monoinfection.

Childs-Kean LM, Egelund EF, Jourjy J. Childs-Kean LM, et al. Among authors: egelund ef. Pharmacotherapy. 2018 Oct;38(10):1051-1057. doi: 10.1002/phar.2174. Epub 2018 Sep 9. Pharmacotherapy. 2018. PMID: 30120841 Review.

4

MenQuadfi (MenACWY-TT): A New Vaccine for Meningococcal Serogroups ACWY.

Huston J, Galicia K, Egelund EF. Huston J, et al. Among authors: egelund ef. Ann Pharmacother. 2022 Jun;56(6):727-735. doi: 10.1177/10600280211039873. Epub 2021 Aug 29. Ann Pharmacother. 2022. PMID: 34459258 Review.

5

Brincidofovir: A Novel Agent for the Treatment of Smallpox.

Huston J, Curtis S, Egelund EF. Huston J, et al. Among authors: egelund ef. Ann Pharmacother. 2023 Oct;57(10):1198-1206. doi: 10.1177/10600280231151751. Epub 2023 Jan 23. Ann Pharmacother. 2023. PMID: 36688308 Review.

6

Posaconazole pharmacokinetics in a 2-year-old boy with rhino-cerebral-orbital zygomycosis.

Egelund EF, Egelund TA, Ng JS, Wassil SK, Peloquin CA. Egelund EF, et al. Among authors: egelund ta. Pharmacotherapy. 2013 Jan;33(1):e1-8. doi: 10.1002/phar.1172. Pharmacotherapy. 2013. PMID: 23307552

7

Population pharmacokinetics and its role in anti-tuberculosis drug development and optimization of treatment.

Egelund EF, Barth AB, Peloquin CA. Egelund EF, et al. Curr Pharm Des. 2011;17(27):2889-99. doi: 10.2174/138161211797470246. Curr Pharm Des. 2011. PMID: 21834766 Review.

8

CYP2C19 polymorphisms and therapeutic drug monitoring of voriconazole: are we ready for clinical implementation of pharmacogenomics?

Owusu Obeng A, Egelund EF, Alsultan A, Peloquin CA, Johnson JA. Owusu Obeng A, et al. Among authors: egelund ef. Pharmacotherapy. 2014 Jul;34(7):703-18. doi: 10.1002/phar.1400. Epub 2014 Feb 7. Pharmacotherapy. 2014. PMID: 24510446 Free PMC article. Review.

9

Optimizing the clinical pharmacology of tuberculosis medications.

Egelund EF, Alsultan A, Peloquin CA. Egelund EF, et al. Clin Pharmacol Ther. 2015 Oct;98(4):387-93. doi: 10.1002/cpt.180. Epub 2015 Jul 22. Clin Pharmacol Ther. 2015. PMID: 26138226 Review.

10

The pharmacological challenges of treating tuberculosis and HIV coinfections.

Egelund EF, Dupree L, Huesgen E, Peloquin CA. Egelund EF, et al. Expert Rev Clin Pharmacol. 2017 Feb;10(2):213-223. doi: 10.1080/17512433.2017.1259066. Epub 2016 Nov 28. Expert Rev Clin Pharmacol. 2017. PMID: 27828731

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page